Retrospective Analysis of Pain After Nerve Block in Surgical Patients

Overview

This is a retrospective study looking at patients who received a nerve block for surgery and assessing pain after the nerve block resolves, with or without an educational intervention, over two periods of time.

Full Title of Study: “Retrospective Analysis of Pain in Patients Who Receive a Nerve Block for Surgery”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: July 31, 2024

Detailed Description

Regional anesthesia (RA) is a vital tool that can serve as the primary anesthetic or as part of a multimodal perioperative pain regimen. RA is strongly associated with decreased acute and persistent pain and opioid consumption postoperatively. However, some patients experience an acute worsening of pain into the severe range around the time of RA resolution, also known as "rebound pain" (RP). The incidence of RP has been reported as high as 40-50% after a single shot nerve block for patients undergoing ambulatory surgery. This retrospective study aims to look at patients who received a nerve block for surgery and assessing pain after the nerve block resolves in the presence and absence of certain interventions, such as a multidisciplinary educational intervention. The investigators will assess patients who received a primary total knee arthroplasty who received a single shot adductor canal nerve block, received pericapsular injection by the surgeon, and had a length of stay > 16 hours.

Interventions

  • Other: Educational intervention
    • Multidisciplinary educational intervention was performed by orthopedic, anesthesia, and nursing team. This included a discussion of the patient’s pain plan and a patient visit.

Arms, Groups and Cohorts

  • TKA with nerve block no intervention
    • Patients who received a single shot adductor canal nerve block prior to total knee arthroplasty surgery January 2017-December 2017
  • TKA with nerve block with intervention
    • Patients who received a single shot adductor canal nerve block prior to total knee arthroplasty surgery during March 2019-March 2020, and received an educational intervention

Clinical Trial Outcome Measures

Primary Measures

  • Overall pain score
    • Time Frame: 8-16 hours
    • Difference in area under the curve of pain scores, numerical pain rating scale 0-10, 8-16 hours after nerve block between the two cohorts (educational intervention and non-educational intervention time periods)

Secondary Measures

  • Difference in maximum pain score post-nerve block
    • Time Frame: 8-16 hours
    • Difference in maximum pain score, numerical pain rating scale 0-10, 8-16 hours after nerve block between the two cohorts
  • Difference in incidence of rebound pain
    • Time Frame: 8-16 hours
    • Difference in incidence pain score ≥ 7 between 8-16 hours post nerve block between the two cohorts

Participating in This Clinical Trial

Inclusion Criteria

  • primary total knee arthroplasty – received an adductor canal nerve block – received pericapsular injection by surgeon intraoperatively – admitted for overnight stay and > 16 hours post-nerve block Exclusion Criteria:

  • age < 18 – prior total knee arthroplasty on ipsilateral knee

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Brigham and Women’s Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Yun-Yun K. Chen, Principal Investigator – Brigham and Women’s Hospital
  • Overall Official(s)
    • Yun-Yun K Chen, MD, Principal Investigator, Brigham and Women’s Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.